NeurogesX Receives FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neura... ( SAN MATEO Calif. Nov. 16 /- Ne...)

NeurogesX Receives FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)

Date:11/16/2009

SAN MATEO, Calif., Nov. 16 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX) announced today that the U.S. Food and Drug Administration (FDA) has approved Qutenza(TM) (capsaicin) 8% patch, the first and only product containing prescription strength capsaicin, for the management of neuropathic pain due to postherpetic neuralgia (PHN), the nerve pain which can follow shingles. Qutenza delivers a synthetic form of capsaicin, the substance in chili peppers that gives them their heat sensation, through a dermal delivery system, providing up to 12 weeks of reduced pain following a single one-hour application. It is the first product from NeurogesX to be approved by the FDA.

"PHN can be an excruciatingly painful condition that can affect many aspects of a patient's quality of life. Despite a variety of medications for pain, undesirable side effects often limit their use and therefore, the treatment of PHN continues to represent a significant unmet need," said Lynn Webster, M.D., Medical Director, Lifetree Clinical Research, Salt Lake City, Utah. "Qutenza may provide a unique treatment option that works at the site of the pain and may be useful as a treatment option in combination with existing therapies."

Qutenza works by targeting certain pain nerves in the area of skin where pain is being experienced. The Qutenza patch is applied by a physician or a healthcare professional. Clinical studies have shown that PHN pain can be reduced for up to 12 weeks following a single one-hour treatment. Up to four patches may be used and patches may be cut to conform to the size and shape of the painful area. Qutenza is a locally-acting, non-narcotic medication that is unlikely to cause drowsiness or have drug-drug interactions. Treatment with Qutenza may be repeated every three or more months as warranted by the return of pain. <
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. NeurogesX Expands Commercial Operations Leadership Team
2. NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results
3. NeurogesX to Present at JMP Securities Healthcare Focus Conference
4. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
5. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
6. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
7. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
8. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
9. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
10. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
11. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy

Post Your Comments:

(Date:6/19/2013)... June 19, 2013 NextDocs announced today ... clinical research organization, at DIA 2013 , the ... will present case studies that explore best practices for ... electronic trial master file (eTMF) systems. ... present alongside Krystyna Kowalczyk , executive vice president ...

(Date:6/19/2013)... 2013 Caradigm today announced the availability ... to help healthcare organizations efficiently manage clinician ... their compliance with data privacy regulations. The ... in the delivery of advanced role lifecycle ... systems. (Photo: http://photos.prnewswire.com/prnh/20130619/SF34463LOGO ...

(Date:6/19/2013)... YORK , June 19, 2013 Voices ... to finding a cure for brain cancer, today announced ... a grant to support the clinical investigation of Toca ... recurrent high grade glioma brain cancer (Grade 3 or ... developing novel treatments for advanced cancer, with an initial ...

Breaking Medicine Technology:NextDocs and Novella to Present on eTMF at DIA 2013 2 Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 2 Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 3 Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2 Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3

[0] NextDocs and Novella to Present on eTMF at DIA 2013 [0] Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk [0] Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer

... and Methods, ROCKVILLE, Md., June 11 ... company developing,therapeutics for the treatment of cancer and ... No. 7,371,741 covering analogs of 2-,methoxyestradiol (2ME2). The ... property protection through 2025 for analogs,of 2ME2 in ...

... 11 , - Data Published in the ... no Negative Impact on Overall Survival or Tumour,Progression, ... randomised, controlled,studies in 2,301 cancer patients shows that ... impact on survival, tumour,progression or deaths caused by ...

Cached Medicine Technology:EntreMed Receives New Patent for 2-Methoxyestradiol Analogs 2 EntreMed Receives New Patent for 2-Methoxyestradiol Analogs 3 New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients 2

EntreMed Receives New Patent for 2-Methoxyestradiol Analogs New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients

(Date:6/20/2013)... Volume based manufacturing savings have allowed ... retail pricing of both it's WHEY TOO GOOD Vanilla ... Premier Natural Health’s whey protein shake drink ... are formulated to help maintain healthy blood sugar levels, ... the aging process. , Ideal for health conscious ...

(Date:6/20/2013)... Michigan-based natural health and wellness coach Carol ... which revealed that performing random acts of kindness – ... of the feel-good hormone Oxytocin in the brain and ... ‘cardio protective’ hormone because it temporarily lowers blood pressure ... “Being kind is something we can all do, doesn’t ...

(Date:6/20/2013)... (PRWEB) June 20, 2013 Creighton ... Education Community Service Honor Roll – the highest federal ... commitment to volunteering, student- service learning and civic engagement ... presented by the Corporation for National and Community Service, ... sixth for Creighton. “Our foundation at Creighton is based ...

(Date:6/19/2013)... 19, 2013 Paleo Burn has finally been ... finally sculpt the body they desire with no fad diets, ... programs and health food products, Ken Smith was bold enough ... consumers an easy, automatic, and permanent solution for weight loss. ... . , After a quick review of Paleo Burn, TotalWellnessCleanse.net ...

(Date:6/19/2013)... June 19, 2013 Go Classy Tours has ... Resorts for over 25 Years. These resorts, draw ... nude pools, nude bars and nude hot tubs. Grand ... alike. When SuperClubs re-branded the resort to a Breezes ... nude side of the Resort fell off dramatically. "Groups ...

Breaking Medicine News(10 mins):Health News:Premier Natural Health, a Leading Provider of Natural Food Products and Herbal Solutions, Reduces Prices On Its Popular Whey Protein Product 2 Health News:Premier Natural Health, a Leading Provider of Natural Food Products and Herbal Solutions, Reduces Prices On Its Popular Whey Protein Product 3 Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 2 Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 3 Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 2 Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 3 Health News:Paleo Burn Review Released by TotalWellnessCleanse.net 2 Health News:The Former Breezes Resort is Re-Opened by Blue Diamond Resorts as the Original Grand Lido Negril Announced Go Classy Tours 2

[0] Premier Natural Health, a Leading Provider of Natural Food Products and Herbal Solutions, Reduces Prices On Its Popular Whey Protein Product [0] Kindness Can Be Good for The Heart Says BioGirl Health Show [0] Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service [0] Paleo Burn Review Released by TotalWellnessCleanse.net [0] The Former Breezes Resort is Re-Opened by Blue Diamond Resorts as the Original Grand Lido Negril Announced Go Classy Tours

... in four men admitted to hospital with acute urinary retention will ... , The risk of death in men after acute urinary retention ... hip. The problem is set to get worse as the population ... sudden inability to pass urine and is often a progression of ...

... Asset Sales and ... Anticipated Pre-Tax Charges ... Va., Nov. 9 Sunrise Senior Living,Inc. (NYSE: SRZ ) today ... 2007. The Company also,provided preliminary information on recapitalizations, asset sales and,anticipated pre- ...

... of chronic hepatitis C and advanced liver disease in ... the disease, a national study in which the Saint ... Patients in the trial who were treated with interferon ... liver inflammation, but the trial unequivocally demonstrated that treatment ...

... benefit from spinal manipulation , , FRIDAY, Nov. 9 ... acute low back pain -- nonsteroidal anti-inflammatory drugs ... patients in a carefully controlled study, Australian researchers ... said, because the evidence for their effectiveness has ...

... Ariz., Nov. 9 Rural/Metro,Corporation (Nasdaq: RURL ) ... quarter ended September 30, 2007 and fiscal 2007 fourth ... opening of markets on November,14, 2007. In conjunction, the ... these results beginning at 9 a.m. (Pacific)/ 11 a.m.,(Eastern). ...

... down due to non-recurring event in 2007, net loss ... in Canadian dollars unless otherwise noted), BELLEVILLE, ON, ... a research-based, technology-driven Canadian,biopharmaceutical company, today announced financial results ... September 30, 2007. "We are also focused on ...

Study reveals high death toll after severe urinary complications in men over 45 Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 Interferon does not slow or stop hepatitis C from worsening, study finds NSAID Drug Therapy Fails to Ease Back Pain Rural/Metro to Host Conference Call to Discuss Results for First Quarter Fiscal 2008 and Fourth Quarter/Fiscal 2007 Year-End Bioniche Reports Fiscal 2008 First Quarter

Valin Hemilaminectomy Retractor, self retaining with rack and pinion action....

Scoville-Haverfield Hemilaminectomy Retractor...

Karlin Crank Frame Spinal Retractor Set is designed for posterior lumbar and thoracic spine surgery. Arm design allows the blades be pre-positioned in the wound prior to attachment....

Panther Universal Spinal Retractor System...

Medicine Products:

Valin Hemilaminectomy Retractor Scoville-Haverfield Hemilaminectomy Retractor Karlin Crank Frame Spinal Retractor Set Panther Universal Spinal Retractor System